EXPERIMENTAL TOXIC HEPATITIS LEADS TO PROGRESSIVE RETINAL NEUROVASCULAR DEGENERATION
Keywords:
Toxic hepatitis; Retina; Retinal morphology; Experimental rats; SilymarinAbstract
Toxic hepatitis is accompanied by pronounced systemic metabolic disturbances that extend beyond hepatic tissue and involve extrahepatic organs, including the retina. The present study was designed to characterize morphological alterations of the retinal layers in an experimental model of toxic hepatitis and to evaluate the potential protective effects of hepatoprotective therapy. Thirty adult rats were randomly allocated into three groups: intact control, toxic hepatitis, and toxic hepatitis treated with silymarin. Retinal specimens were subjected to histological and histochemical examination using hematoxylin–eosin, periodic acid–Schiff (PAS), Nissl staining, and silver impregnation techniques. Induction of experimental toxic hepatitis led to marked disorganization of retinal laminar architecture, thickening of retinal vascular walls, degeneration of photoreceptor elements, and a significant decrease in ganglion cell density (p < 0.05). PAS staining demonstrated enhanced accumulation of glycoprotein components within the walls of retinal microvessels, indicating metabolic and structural vascular impairment. Administration of silymarin resulted in partial attenuation of both vascular and neuronal damage; however, complete restoration of normal retinal morphology was not achieved. Overall, the obtained results indicate that retinal structural alterations mirror systemic toxic injury associated with experimental toxic hepatitis, supporting the retina as a sensitive morphological indicator of extrahepatic manifestations of hepatic pathology.
References
Weber, L. W. D., Boll, M. & Stampfl, A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33, 105–136 (2003).
Recknagel, R. O., Glende, E. A., Dolak, J. A. & Waller, R. L. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Ther. 43, 139–154 (1989).
Jaeschke, H., McGill, M. R. & Ramachandran, A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury. Drug Metab. Rev. 44, 88–106 (2012).
Polyak, S. J., Morishima, C., Lohmann, V., Pal, S. & Lee, D. Y. Identification of hepatoprotective flavonolignans from silymarin. Proc. Natl. Acad. Sci. U.S.A. 107, 5995–5999 (2010).
Vargas-Mendoza, N. et al. Hepatoprotective effect of silymarin. World J. Hepatol. 6, 144–149 (2014).
Cunha-Vaz, J. The blood–retinal barriers system. Basic concepts and clinical evaluation. Exp. Eye Res. 78, 715–721 (2004).
Antonetti, D. A., Klein, R. & Gardner, T. W. Diabetic retinopathy. N. Engl. J. Med. 366, 1227–1239 (2012).
Osborne, N. N. et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91–147 (2004).
Kolb, H., Fernandez, E. & Nelson, R. Webvision: The Organization of the Retina and Visual System. (University of Utah Health Sciences Center, 2019).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 GEJournals

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.